Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

1.

Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.

Michiels JJ, Budde U, van der Planken M, van Vliet HH, Schroyens W, Berneman Z.

Best Pract Res Clin Haematol. 2001 Jun;14(2):401-36. Review.

PMID:
11686107
[PubMed - indexed for MEDLINE]
2.

Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.

Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, Budde U, van Vliet HH.

Semin Thromb Hemost. 2006 Sep;32(6):577-88. Review.

PMID:
16977568
[PubMed - indexed for MEDLINE]
3.

Acquired von Willebrand syndrome: features and management.

Mohri H.

Am J Hematol. 2006 Aug;81(8):616-23. Review.

PMID:
16823821
[PubMed - indexed for MEDLINE]
4.

Acquired von Willebrand syndrome--report of 10 cases and review of the literature.

Nitu-Whalley IC, Lee CA.

Haemophilia. 1999 Sep;5(5):318-26. Review.

PMID:
10583513
[PubMed - indexed for MEDLINE]
5.

Laboratory diagnosis and molecular classification of von Willebrand disease.

Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.

Acta Haematol. 2009;121(2-3):71-84. doi: 10.1159/000214846. Epub 2009 Jun 8. Review.

PMID:
19506352
[PubMed - indexed for MEDLINE]
6.

Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.

Michiels JJ, Gadisseur A, Budde U, Berneman Z, van der Planken M, Schroyens W, van de Velde A, van Vliet H.

Semin Thromb Hemost. 2005 Nov;31(5):577-601. Review.

PMID:
16276467
[PubMed - indexed for MEDLINE]
7.

Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine.

Michiels JJ, Schroyens W, Berneman Z, van der Planken M.

Clin Appl Thromb Hemost. 2001 Apr;7(2):113-5. Review.

PMID:
11292187
[PubMed - indexed for MEDLINE]
8.

Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.

Michiels JJ, van Vliet HH.

Acta Haematol. 2009;121(2-3):154-66. doi: 10.1159/000214856. Epub 2009 Jun 8. Review.

PMID:
19506362
[PubMed - indexed for MEDLINE]
9.

Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome.

Federici AB.

Hum Immunol. 2005 Apr;66(4):422-30. Review.

PMID:
15866707
[PubMed - indexed for MEDLINE]
11.

Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.

Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.

Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. Review.

PMID:
17164493
[PubMed - indexed for MEDLINE]
12.

Acquired von Willebrand syndrome 2004: International Registry--diagnosis and management from online to bedside.

Federici AB, Budde U, Rand JH.

Hamostaseologie. 2004 Feb;24(1):50-5. Review.

PMID:
15029273
[PubMed - indexed for MEDLINE]
13.

Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.

Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, van Vliet H.

Clin Appl Thromb Hemost. 2006 Jul;12(3):277-95. Review.

PMID:
16959681
[PubMed - indexed for MEDLINE]
14.
15.

Acquired von Willebrand syndrome: its pathophysiology, laboratory features and management.

Mohri H.

J Thromb Thrombolysis. 2003 Jun;15(3):141-9. Review.

PMID:
14739623
[PubMed - indexed for MEDLINE]
16.

Acquired von Willebrand's syndrome: a single institution experience.

Kumar S, Pruthi RK, Nichols WL.

Am J Hematol. 2003 Apr;72(4):243-7. Review.

PMID:
12666134
[PubMed - indexed for MEDLINE]
17.

Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis, and treatment.

Tefferi A, Nichols WL.

Am J Med. 1997 Dec;103(6):536-40. Review.

PMID:
9428838
[PubMed - indexed for MEDLINE]
18.

Screening and diagnosis of coagulation disorders.

Lusher JM.

Am J Obstet Gynecol. 1996 Sep;175(3 Pt 2):778-83. Review.

PMID:
8828561
[PubMed - indexed for MEDLINE]
19.

Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.

Gadisseur A, van der Planken M, Schroyens W, Berneman Z, Michiels JJ.

Acta Haematol. 2009;121(2-3):145-53. doi: 10.1159/000214855. Epub 2009 Jun 8. Review.

PMID:
19506361
[PubMed - indexed for MEDLINE]
20.

Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.

Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, van Vliet H.

Clin Appl Thromb Hemost. 2006 Oct;12(4):397-420. Review.

PMID:
17000885
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk